Sakellaris, D
7) Improved gut & immune health (microbiome effects are being studied) Systematic reviews suggest GLP-1 analogues may influence the composition and diversity of gut microbiota , though findings vary across medications and populations
Real-world outcomes from clinical practice settings confirm that results vary based on individual metabolism, genetics, and commitment to the treatment protocol
01Dose tracking that matches the label Tirzepatide's schedule (2.5 mg 5 mg 7.5 mg 10 mg 12.5 mg 15 mg) is built in
Treatment is complex, and therapeutic options include topical, intralesional, or systemic corticosteroids, retinoids, methotrexate, antimalarials, dapsone, and biologic therapies (adalimumab, secukinumab).6,7,33 Trachyonychia Two subtypes of trachyonychia have been described based on the clinical presentation: opaque or sandpaper trachyonychia and shiny trachyonychia
32%) and similar to that with liraglutide 3.0 mg (60%)
